Keyphrases
D2 Receptor
100%
Dopamine D2 Receptor (DRD2)
100%
Bromocriptine
100%
Transactivation
100%
Phosphoinositide 3-kinase Signaling Pathway
100%
Epidermal Growth Factor Receptor
83%
C-Src
83%
Phosphoinositide 3-kinase (PI3K)
50%
PC12
50%
Oxidative Stress
33%
Phosphorylation
33%
Tyrosine
33%
Cytoprotection
33%
Akt Activation
33%
Apoptosis
16%
G Protein
16%
Signaling Cascades
16%
Receptor-mediated
16%
Signaling Pathway
16%
Co-immunoprecipitation (co-IP)
16%
G Protein Signaling
16%
Receptor Signaling
16%
Protein Kinase B/Akt
16%
RNA Interference
16%
Dominant Negative
16%
Src Kinase
16%
Dopamine Agonist
16%
Receptor Phosphorylation
16%
Src Kinase Inhibitor
16%
Dopamine Cells
16%
Pramipexole
16%
Epidermal Growth Factor Receptor Transactivation
16%
Neuroscience
Agonist
100%
Cell Signaling
100%
Epidermal Growth Factor Receptor
100%
Phosphoinositide 3-Kinase
100%
Dopamine Receptor D2
100%
Transactivation
100%
Bromocriptine
100%
Receptor
100%
Oncogene Src
83%
G Protein
33%
Oxidative Stress
33%
Kinase
16%
Tyrosine Kinase Inhibitor
16%
Dopamine Agonist
16%
Immunoprecipitation
16%
Pramipexole
16%
Receptor Phosphorylation
16%
Protein Kinase B
16%
RNAI
16%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Epidermal Growth Factor Receptor
100%
Dopamine Receptor D2
100%
Phosphatidylinositol 3 Kinase
100%
Bromocriptine
100%
Cytoprotective Agent
50%
Guanine Nucleotide Binding Protein
33%
Cytoprotection
33%
Phosphotransferase
16%
Protein Tyrosine Kinase Inhibitor
16%
Protein Kinase B
16%
Dopamine Receptor Stimulating Agent
16%
Pramipexole
16%
Immunoprecipitation
16%